Simon Jules Nebel
Président chez MARINOMED BIOTECH AG
Provenance du réseau au premier degré de Simon Jules Nebel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Basel
48
| College/University | Other Consumer Services | 48 |
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.
22
| Private Company | Investment Managers | 22 |
| Public Company | Pharmaceuticals: Major | 13 | |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
Quadia SA
 Quadia SA Investment ManagersFinance Quadia SA (Quadia) is an independent investment firm founded in 2010. The firm is headquartered in Switzerland.
9
| Private Company | Investment Managers | 9 |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA.
3
| Subsidiary | Biotechnology | 3 |
Viopas Partners AG
 Viopas Partners AG Investment ManagersFinance Zoeyplus AG(Zoeyplus) is a Private Equity subsidiary of Viopas Venture Consulting GmbH founded in 2018 by Simon Jules Nebel, Nathalie Flury and Michael Schröter. The firm is headquartered in Zurich, Switzerland.
2
| Extinct | Investment Managers | 2 |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland.
2
| Private Company | Investment Managers | 2 |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award.
2
| Private Company | Pharmaceuticals: Major | 2 |
DyCare
 DyCare Medical SpecialtiesHealth Technology DyCare is a Spanish company that specializes in digital rehabilitation. The company is based in Barcelona, Spain. The company creates ultra-personalized exercises and monitor patients in a simple and effective way. The company's technology allows patients to perform therapeutic exercises using only their mobile phone or tablet camera, assisted by artificial intelligence. The company was founded by Silvia Raga and Ricardo Jauregui, who have been the CEOs since incorporation.
2
| Holding Company | Medical Specialties | 2 |
ImVisioN Therapeutics AG
 ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services ImVisioN Therapeutics AG is a Swiss, clinical stage immunotherapy company developing novel treatments to cure allergies. The Company is the pioneer in intralymphatic immunotherapy (ILIT ™), a proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. ILIT ™ is clinically proven and has been shown to be a safer, more efficacious and more convenient means of delivering allergy therapeutics. By applying another proprietary technology, Modular Antigen Transportation ™ (MAT ™), ImVisioN leverages the potential of ILIT ™ to develop drugs that use allergens safely for specific and highly effective antigen presentation. ImVisioN's lead product is for the treatment of cat dander allergy and the Company has programs addressing birch pollen and house dust mite allergies. The Company's proprietary technology platforms are applicable to further allergy targets, which may be addressed in the future.
1
| Extinct | Miscellaneous Commercial Services | 1 |
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Simon Jules Nebel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| UBS | Investment Managers | Corporate Officer/Principal Comptroller/Controller/Auditor | |
RIGI BAHNEN AG
 RIGI BAHNEN AG Other Consumer ServicesConsumer Services RIGI BAHNEN AG operates cog railway trains and cable cars. It also runs hotels, inns, holiday apartments, cottages, and restaurants. The company was founded in 1883 and is headquartered in Vitznau, Switzerland. | Other Consumer Services | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer | |
| STRAUMANN HOLDING AG | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| BACHEM HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| BASLER KANTONALBANK | Regional Banks | Chairman Director/Board Member | |
| JUNGFRAUBAHN HOLDING AG | Railroads | Chairman | |
| BANK CLER AG | Regional Banks | President Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Vienna | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of St. Gallen | College/University | Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
Penn Pharmaceutical Services Ltd.
 Penn Pharmaceutical Services Ltd. Pharmaceuticals: MajorHealth Technology Penn Pharmaceutical Services Ltd. provides drug development, clinical trial supply and pharmaceutical manufacturing services. Its services include solid oral and topical products formulation, pilot batches scale up and testing, clinical trials supplies manufacturing, process validation and technology transfer, formulation and analytical development, clinical trial packing and labeling, and storage and distribution. The company was founded in 1977 and is headquartered in Tredegar, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| University of Zurich | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| University of Bayreuth | College/University | Graduate Degree Masters Business Admin | |
| Université de Neuchâtel | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Lausanne | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Tertianum AG
 Tertianum AG Medical/Nursing ServicesHealth Services TERTIANUM AG provides senior residential care services. It also engages in the acquisition, holding, management, and sale of real estate. In addition, the firm specializes in the purchasing, continuous management, and sale of shares to domestic and foreign companies. The company was founded on October 13, 1978 and is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member | |
| SYMETIS SA | Biotechnology | Chief Executive Officer Director/Board Member | |
AndersonBrecon (UK) Ltd.
 AndersonBrecon (UK) Ltd. Containers/PackagingProcess Industries AndersonBrecon (UK) Ltd. specializes in packaging products for pharmaceutical products. The company is headquartered in Cardiff, the United Kingdom. | Containers/Packaging | Director/Board Member | |
Vischer AG
 Vischer AG Miscellaneous Commercial ServicesCommercial Services Vischer AG provides legal advisory services. The private company is based in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Partners Group (Private Equity)
 Partners Group (Private Equity) Investment ManagersFinance Partners Group (Private Equity) (Partners Group-PE) is the private equity division of Partners Group AG, itself a subsidiary of Partners Group Holding AG (SW: PGHN), founded in 1996. It is headquartered in Baar, Switzerland. The firm seeks opportunities to create value through working with investee management teams to expand their businesses and attain leadership positions in their markets. Partners Group-PE aligns interests by investing alongside clients. | Investment Managers | Private Equity Investor | |
Viessmann Holding AG
 Viessmann Holding AG Wholesale DistributorsDistribution Services Viessmann Holding AG provides heating and air-conditioning equipment and supplies. The private company is based in Basel, CH and has subsidiaries in Spain, Netherlands, and United Kingdom. | Wholesale Distributors | Director/Board Member | |
| EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member Director of Finance/CFO Founder Founder Corporate Officer/Principal Director/Board Member | |
| Swiss Air Transport Foundation | Corporate Officer/Principal | ||
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Chairman Director/Board Member | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Jungfraubahnen Management AG
 Jungfraubahnen Management AG RailroadsTransportation Jungfraubahnen Management AG provides management and consulting services to companies that focus on the transportation and tourism industry. The company was founded on February 16, 2000 and is headquartered in Interlaken, Switzerland. | Railroads | Chairman | |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
| Roche Singapore Pte Ltd. | Corporate Officer/Principal | ||
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
PricewaterhouseCoopers AG (Basel)
 PricewaterhouseCoopers AG (Basel) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers AG provides tax preparation services. The company is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chairman Comptroller/Controller/Auditor | |
Voyage Holdings Ltd.
 Voyage Holdings Ltd. Services to the Health IndustryHealth Services Voyage Holdings Ltd. operates as a holding company which engages in the provision of specialist care and support. It offers care homes, supported living, nurse-led homecare, respite care, support at home, day oportunities, focused healthcare, and nursing care home services. It helps people with a range of needs such as learning disabilities, autism, brain injury rehabilitation, Prader-Willi syndrome, physical disabilities, complex are needs, mental health conditions, people in transition, intensive requirements, nursing needs, and challenging behaviour. The company was founded in 2009 and is headquartered in Lichfield, the United Kingdom. | Services to the Health Industry | Director/Board Member | |
| Rheumaliga beider Basel | Corporate Secretary | ||
| Europa Institute at the University of Zurich | Director/Board Member Director/Board Member | ||
| NANEXA AB | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
HSBC Global Asset Management (Switzerland) AG
 HSBC Global Asset Management (Switzerland) AG Investment ManagersFinance Part of HSBC Holdings Plc, HSBC Global Asset Management (Switzerland) AG provides investment advice. The company is based in Zurich, Switzerland. Isabelle Brancart has been the CEO of the Swiss company since 2019. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
Pioneer UK Midco 1 Ltd.
 Pioneer UK Midco 1 Ltd. Financial ConglomeratesFinance Pioneer Uk Midco 1 Ltd. functions as investment holding company. The company is headquartered in London, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Eli Lilly (Singapore) Pte Ltd.
 Eli Lilly (Singapore) Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly (Singapore) Pte Ltd. is a Singaporean pharmaceutical company that manufactures pharmaceutical products. The company is based in Singapore, Singapore. | Pharmaceuticals: Major | Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Secretary | |
Strongwind Holding AG
 Strongwind Holding AG Electric UtilitiesUtilities Strongwind Holding AG owns and operates wind park. The company is headquartered in Zurich, Switzerland. | Electric Utilities | Director/Board Member Chairman Director/Board Member Director/Board Member |
Statistiques
Internationale
| Suisse | 35 |
| Royaume-Uni | 5 |
| Etats-Unis | 4 |
| Danemark | 3 |
| Allemagne | 3 |
Sectorielle
| Health Technology | 17 |
| Consumer Services | 9 |
| Finance | 8 |
| Commercial Services | 5 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 336 |
| Corporate Officer/Principal | 152 |
| Chairman | 75 |
| Chief Executive Officer | 54 |
| Private Equity Investor | 44 |
Relations les plus connectées
| Insiders | |
|---|---|
| Stefan Mario Meister | 57 |
| Søren Lemonius | 39 |
| Jürgen Eckhardt | 34 |
| Guido Magni | 23 |
| Brigitte Ederer | 22 |
| Paul Grayson | 21 |
| Patrick Frost | 21 |
| Jean-Philippe Tripet | 20 |
| Gert Thönen | 19 |
| Neil Goldsmith | 19 |
| Matthias Alder | 18 |
| Rolf Soiron | 18 |
| Beat Oberlin | 17 |
| Edgar F. Fluri | 15 |
| Ralph-Thomas Honegger | 14 |
- Bourse
- Insiders
- Simon Jules Nebel
- Connexions Sociétés
